Covishield and Covaxin are both COVID-19 vaccines developed to combat the spread of the coronavirus. Covaxin, developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), and Covishield, developed by AstraZeneca and Oxford University were the two most highly acceptable vaccines across the country. In this article, we will discuss in detail the types of vaccines, doses, efficacy, and more.
What is coronavirus?
Coronavirus refers to a family of viruses that cause illness ranging from the common cold to more severe respiratory diseases. The most recent strain, known as SARS-CoV-2, is responsible for the COVID-19 pandemic. This novel coronavirus primarily spreads through respiratory droplets when an infected person coughs, sneezes, or talks. Symptoms of COVID-19 include fever, cough, shortness of breath, fatigue, body aches, loss of taste or smell, and in severe cases, pneumonia or organ failure. As of now, vaccines and preventive measures like wearing masks, practicing hand hygiene, and social distancing remain crucial in controlling the spread of the virus.
Read more: Download the CoWIN Vaccine Certificate
Covaxin vs Covishield
Given below is the difference between covishield and covaxin:
Aspect |
Covishield |
Covaxin |
Developed by |
It was created through collaboration between the Jenner Institute at Oxford University and the European pharmaceutical company AstraZeneca. |
Bharat Biotech's Covaxin, India's homegrown COVID-19 vaccine, has been created in partnership with the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV). |
Technology |
Viral vector vaccine |
Inactivated virus vaccine |
Approval |
Emergency use authorisation in India, WHO approval |
Emergency use authorisation in India |
Doses |
Two doses, administered 4 to 12 weeks apart |
Two doses, administered 28 days apart |
